July 31, 2021 ‐ July 30, 2022
Target Audience: This activity is designed for physicians, psychologists, nurse, occupational therapists, and advanced practice providers.
Please feel free to peruse the linked document for instructions on how to claim credit.
Anne Marie Albano, PhD, ABPP
Professor of Medical Psychology (in Psychiatry)
Columbia University Irving Medical Center
New York, NY
Adam B. Lewin, PhD, ABPP
Professor of Pediatrics & Psychiatry
Division Chief
Pediatric Neuropsychiatry Director
USF Rothman Center and Tourette Center of Excellence
USF Morsani College of Medicine
USF Rothman Center for Neuropsychiatry
St. Petersburg, Florida
Omar Rahman, PhD
Associate Professor of Pediatrics
USF Morsani College of Medicine
USF Rothman Center for Neuropsychiatry
St. Petersburg, FL
Justyna Wojas, MD
Attending Psychiatrist, USF Department of Pediatrics
USF Rothman Center for Neuropsychiatry
St. Petersburg, FL
Kristen Muller‐Vahl, MD
Professor of Psychiatry
Department of Psychiatry
Hannover Medical School
Hannover, Germany
After participating in this activity, the learner will be able to:
Adam B. Lewin, PhD, ABPP
Professor and Chief, USF Pediatric Neuropsychiatry
All individuals in a position to influence content have disclosed toUSF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.
Kristen Muller‐Vahl, MD
Advisory Board or Panel from CannaMedical Pharma GmbH, Bionorica Ethics GmbH, CannaXanGmbH, Canopy Growth, Columbia Care, Sanity Group, Syqe Medical Ltd., and Therapix Biosciences Ltd; Consultant ‐ Abide Therapeutics, Boehringer Ingelheim International GmbH, Bionorica Ethics GmbH, CannaMedical Pharma GmbH, Canopy Growth, Columbia Care, CTC Communications Corp., Demecan, Eurox Deutschland GmbH, Lundbeck, Sanity Group,Stadapharm GmbH, Synendos Therapeutics AG, and Tilray.Grants/Research Support ‐ EU (FP7‐HEALTH‐2011 No. 278367 and GW pharmaceuticals, Almirall Hermal GmbH, Abide Therapeutics, and Therapix Biosciences.
Justyna Wojas, MD
Grants/Research Support from Emalex Biosciences and Allergan Pharmaceuticals. Terminated Grants/Research Support – Otsuk Pharmaceuticals, Teva Branded Pharmaceuticals, Hoffman‐LaRoche, Pfizer, and NeurocrineBiosciences.
ACCME
USF Health is accredited by the Accreditation Council for Continuing Medical Education(ACCME) to provide continuing medical education for physicians.
USF Health designates this enduring material for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Florida Board of Medicine
USF Health is an approved provider of continuing education for physicians through the Florida Board of Medicine. This activity has been reviewed and approved for
3.5 continuing education credits.
Florida Board of Nursing:
USF Health (provider number 2970) is an approved provider of continuing education for nurses through Florida Board of Nursing. This activity has been approved for 3.5 contact hours.
Florida Board of Occupational Therapists:
USF Health is an approved provider of continuing education for Occupational Therapy licensees by the Florida Board of Occupational Therapists. This program has been reviewed and approved for up to 4.0, 50-minute contact hours.
Florida Board of Psychology:
USF Health is an approved provider of continuing education for Psychologists through the Florida Board of Psychology (provider number 2970). This activity has been reviewed and approved for up to 3.5 continuing education credits.
Disclaimer
The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options for a specific patient’s medical condition.